Yukon Wealth Management, Inc. Anavex Life Sciences Corp. Transaction History
Yukon Wealth Management, Inc.
- $280 Billion
- Q2 2025
A detailed history of Yukon Wealth Management, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Yukon Wealth Management, Inc. holds 17,149 shares of AVXL stock, worth $190,010. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,149
Previous 17,149
-0.0%
Holding current value
$190,010
Previous $147 Million
7.46%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
201Shares Held
30.9MCall Options Held
1.32MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$70.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$54.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$35.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$22.4 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1.02MShares$11.4 Million0.83% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $864M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...